I understand your point eight, but I believe at some point in the future CMP needs to streamline/focus it's divisions and products. In my opinion this is also the intent of management as well with their "capitalization review".
In the end, CMP is a circa $30m business. Long term, the best outcome for shareholders will be to focus on the best parts of the business and focus the limited capital into that for the best return, rather than support numerous business divisions.
DWL is a good business. However it doesn't have the same potential (that I can see) of eHealth and the Somfit product. I think it makes sense for CMP to sell DWL (which I believe they could get a price that would re-rate the company immediately) and then deploy those funds into monetizing the eHealth and Somfit product.
CMP Price at posting:
23.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)